Thomas Lohmann, MD
Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Pathology and Laboratory Medicine, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 1979 | Louisiana State University, Shreveport, Louisiana, US, Doctor of Medicine |
| University of New Orleans, New Orleans, Louisiana, US, B.S., Pre-Medical |
Postgraduate Training
| 1979-1983 | Postgraduate Fellow, Anatomic and Clinical Pathology, Alton-Ochsner Medical Foundation, New Orleans, Louisiana |
Licenses & Certifications
| 2024 | State of Nevada |
| 2017 | State of Florida |
| 2014 | Diplomate of The American Board of Pathology |
| 2006 | State of Texas |
| 1998 | Subspecialty in Hematopathology: The American Board of Pathology |
| 1985 | Subspecialty in Chemical Pathology: The American Board of Pathology |
| 1983 | Anatomic & Clinical Pathology: The American Board of Pathology |
| 1983 | State of Louisiana |
Experience & Service
Faculty Academic Appointments
Affiliate Professor of Pathology and Laboratory Medicine, Nova Southeastern University's Dr. Kiran C. Patel College of Allopathic Medicine, Davie, Florida, 2018 - 2024
Associate Professor of Pathology and Immunology, Baylor College of Medicine, Texas, 2016 - 2017
Assistant Professor, Department of Pathology, Texas A&M, Texas, 2008 - 2014
Ochsner Pathology Residency Program Instructor, Department of Clinical Chemistry, Clinical Microscopy, Hematology, Ochsner Foundation Hospital, New Orleans, Louisiana, 1983 - 1992
Administrative Appointments/Responsibilities
Director of Chemistry, Department of Pathology Residency, Baylor College of Medicine, Houston, Texas, 2016 - 2017
Director of Clinical Pathology Residency, Baylor University Medical Center, Dallas, Texas, 2006 - 2014
Other Professional Positions
Global Medical Director of Autoimmunity, Thermo Fisher Immunodiagnostics Division, 2022 - 2024
Director of Medical and Scientific Affairs, Sebia USA, Inc, Norcross, Georgia, 2019 - 2022
Chief Medical Officer, Forward Pathology Solutions, HCA, Ft. Lauderdale, Florida, 2017 - 2018
Clinical Pathologist, Baylor College of Medicine/St. Luke's Medical Center, Houston, Texas, 2016 - 2017
Chief Executive Officer, Sonic Healthcare USA, 2014 - 2015
Chief Medical Officer, med fusion and ClearPoint, 2010 - 2014
Director of Clinical Pathology, Baylor Healthcare System, 2006 - 2010
Global Medical Director, Quintiles Laboratories Limited, Smyrna, Georgia, 2000 - 2006
Medical Director of Lab, Chemistry, Hematology, Special Chemistry, Toxicology, Ochsner Clinic - Ochsner Foundation Hospital, Louisiana, 1983 - 2000
Honors & Awards
| Phi Beta Kappa, University of New Orleans | |
| Alpha Omega Alpha National Medical Honor Society, LSU Medical Center, Shreveport Chapter | |
| Graduated Summa Cum Laude, University of New Orleans |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2017. High Sensitivity Troponin in Acute Cardiac Injury. Houston, Texas, US.
- 1990. "Drug Screening, DOT Rules, Medical Review Officer". New Orleans, Louisiana, US.
Regional Presentations
- 2007. Global Clinical Trial Support: The Role of a Central Laboratory, Texas, US.
- 1996. Biochemical Markers of Myocardial Injury. St. Anne's Hospital Grand Rounds, US.
- 1994. Network Strategies for the Clinical Laboratory - A Practical Approach. AACC National Convention. New Orleans, Louisiana, US.
- 1993. Biochemical Markers of Myocardial Injury. ASCP Spring Meeting. New Orleans, Louisiana, US.
- 1991. Interpretive Algorithm for Coulter STKS 5-Part Differential Application. Coulter Users Forum. New Orleans, Louisiana, US.
- 1990. Diseases Affecting Phlebotomy. American Society of Phlebotomy Technicians. New Orleans, Louisiana, US.
- 1988. "Strategies for Diagnosing Monoclonal Gammopathies". Industry Sponsored Workshop. New Orleans, Lousiana, US.
- 1988. Worshop Moderator - Drug Testing: Legal Update. Americal Occupational Health Conference National Meeting. New Orleans, Louisiana, US.
- 1984. Fetal Lung Maturity Testing. Invited. Gulf Coast Medical Symposium, US.
National Presentations
- 2021. New Approaches to Myeloma Screening and Monitoring, US.
- 2020. The Effect of Red Cell Survival Times on the Clinical Utility of HbA1c, US.
- 2019. RBC Survival Affects HBA1c Results, US.
- 2006. Transitioning Biomarkers from Pre-Clinical to Phase III and Beyond. Las Vegas, Nevada, US.
- 2006. Traditional Clinical Development Methodologies vs. Technical Development Methodologies. Las Vegas, Nevada, US.
- 2001. Global Harmonization of Central Laboratory Data. AAPS National Meeting - Symposium on QA Techiniques. Denver, Colorado, US.
- 1997. Evaluation of Tosoh 2.2 Hb A1c Analyzer. Industry Sponsored Workshop. AACC National Meeting. Atlanta, Georgia, US.
- 1993. Future Advances in Immunoassay Testing - Physician Member - Medical Advisory Panel. Washington, District of Columbia, US.
- 1993. Automation of Immunoassay Testing-Strategies for Improved Patient Care, US.
- 1993. "Organon Teknika MDA 180 Alpha Site Evaluation Update" Satellite Symposium. New York, NY, US.
- 1988. Workshop on Drug Abuse Testing. Northeast Regional AACC Meeting. Lexington, Massachusetts, US.
- 1988. Drug Testing: Legal Update. American Occupational Health Conference National Meeting. New Orleans, Louisiana, US.
- 1987. Urinary Drug Abuse Testing (A Workshop sponsored by Instrumentation Laboratories). Houston, Texas, US.
- 1987. Urinary Drug Abuse Testing (A Workshop sponsored by Instrumentation Laboratories). San Antonio, Texas, US.
- 1987. Urinary Drug Abuse Testing (A Workshop sponsored by Instrumentation Laboratories). Tulsa, Oklahoma, US.
- 1987. Urinary Drug Abuse Testing (A workshop sponsored by Instrumentation Laboratories). Springfield, Illinois, US.
Selected Publications
Peer-Reviewed Articles
- Money SR, Ballinger BA, Crockett DE Jr, Chatman DM, Lohmann TP. The effects of supraceliac aortic clamping on the anticoagulant effects of heparin. Am J Surg 172(2):155-7, 1996. e-Pub 1996. PMID: 8795520.
- Reisin E, Azar S, DeBoisblanc BP, Guzman MA, Lohmann T. Low calorie unrestricted protein diet attenuates renal injury in hypertensive rats. Hypertension 21(6 Pt 2):971-4, 1993. e-Pub 1993. PMID: 8505109.
- Bluth EI, Lambert DJ, Lohmann TP, Franklin DN, Bourgeois M, Kardinal CG, Dalovisio JR, Williams MM, Becker AS. Improvement in 'stat' laboratory turnaround time. A model continuous quality improvement project. Arch Intern Med 152(4):837-40, 1992. e-Pub 1992. PMID: 1558443.
- Dearing BD, Lavie CJ, Lohmann TP, Genton E. Niacin-induced clotting factor synthesis deficiency with coagulopathy. Arch Intern Med 152(4):861-3, 1992. e-Pub 1992. PMID: 1558449.
- Lohmann TP, Beckman EN. Progressive myelofibrosis in agnogenic myeloid metaplasia. Arch Pathol Lab Med 107(11):593-4, 1983. e-Pub 1983. PMID: 6688716.
Invited Articles
- Lohmann T, Wagner M. Hyperglycemia associated with hospitalization for sever COVID-19 infection. Medical Laboratory Observer, 2020. e-Pub 2020.
- Lohmann T. Clinical and diagnostic considerations for diabetes mellitus. Medical Laboratory Observer, 2019. e-Pub 2019.
- Lohmann T. The Impact of Red Blood Cell Lifespan on Hba1c Measurement. Medical Laboratory Observer, 2019. e-Pub 2019.
- Lohmann T. Biochemical Markers of Myocardial Injury. Advance/Laboratory 5(4), 1996. e-Pub 1996.
- Lohmann T. Digoxin- An Old Drug Improved by Laboratory Monitoring. Syva Monitor 12(No.1), 1994. e-Pub 1994.
Abstracts
- Lohmann T. Free Thryroxin (FT4) Estimation in Pregnancy. 1987 AACC National Convention.
- Lohmann T. Evaluation of Homogeneous Enzyme Immunoassays for T-4 & T-uptake on Cobas-BIO Centrifugal Analyzer. 1988 AACC National Convention.
- Lohmann T. Performance Characteristics of Urinary Amylase and Urinary Creatinine on Paramax. 1988 AACC National Convention.
- Lohmann T. Performance Characteristics of Urinary Magnesium and Phosphorus on Paramax. 1988 AACC National Convention.
- Lohmann T. Low Calorie Diet Without Protein Restriction Blocks the Increase of Proteinuria and Preserve Creatinine Clearance in Uninephrectomized Spontaneously Hypertensive Rats. American Society of Hypertension - Seventh Scientific Meeting.
- Lohmann T. Comparison of Abbott's FLM with L/S and PG for Prediction of Respiratory Distress Syndrome. 1993 ASCP Fall Meeting.
- Lohmann T. Is Total PSA Assay Behavior Predicted by Responses to the Stanford PSA reference Materials?. 1996 ISOBM Meeting.
- Lohmann T. Stability of Free Prostatic Specific Antigen (FPSA) as Estimated by the DPC Immulite Assay. 1996 ISOBM Meeting.
Patient Reviews
CV information above last modified March 26, 2026